Stress and Alopecia Areata: Can Stress Really Trigger Patchy Hair Loss?

Alopecia areata is an autoimmune condition in which the immune system attacks hair follicles, most often causing smooth, round patches of hair loss on the scalp, beard, or eyebrows. In some people it progresses to loss of all scalp hair or body hair. The American Academy of Dermatology notes that the follicles are usually not destroyed, which is why hair can regrow, sometimes on its own. Because patches often appear suddenly, many people link them to a recent difficult period, and the phrase "stress bald spot" is common online. The real relationship is more nuanced.

First, it helps to separate alopecia areata from the more common stress-related shedding called telogen effluvium. Telogen effluvium typically causes diffuse thinning across the whole scalp a few months after a major stressor such as illness, surgery, or childbirth, and it usually resolves once the trigger passes. Alopecia areata looks different: distinct bald patches, sometimes with short broken hairs at the edges, and it is driven by immune activity rather than a simple shift in the hair growth cycle. A dermatologist can usually tell them apart by examining the scalp.

Stress does appear in the research on alopecia areata, mostly as a possible trigger. Several case-control and survey studies have found that people with the condition report stressful life events before onset or relapse more often than comparison groups, though the reported share varies widely between studies, from roughly a quarter to around three quarters of patients. These studies rely on people recalling events after the fact, which can inflate the link, since people naturally search for an explanation when something alarming happens. Researchers generally describe stress as one potential trigger in people who are already genetically susceptible, not as a cause on its own.

There is a plausible biological story. Hair follicles normally enjoy a kind of "immune privilege" that keeps the immune system from attacking them. A 2023 review in the International Journal of Molecular Sciences by Ahn and colleagues summarized laboratory and animal work suggesting that stress-related signals, including corticotropin-releasing hormone and substance P released by nerves in the skin, may help weaken that protection and promote inflammation around the follicle. Much of this evidence comes from mouse and cell studies, so it supports the idea that stress can contribute, but it does not show how much stress matters for any individual person.

The relationship also runs the other way. Studies consistently find higher rates of anxiety and depression among people with alopecia areata, and visible hair loss can itself be a major source of stress. On the treatment side, the most important recent development has nothing to do with stress management: the FDA has approved JAK inhibitor pills, including baricitinib in 2022, ritlecitinib in 2023, and deuruxolitinib in 2024, for severe alopecia areata. Steroid injections and other dermatologist-prescribed options remain common for smaller patches.

So what is proven and what is trend? Well supported: alopecia areata is an autoimmune condition with a strong genetic component, and effective medical treatments now exist. Reasonably supported: stress may act as a trigger for onset or flares in some susceptible people, and living with the condition is often stressful. Trend and marketing: claims that lowering cortisol with supplements, teas, or scalp serums will reverse alopecia areata. Managing stress is worthwhile for overall wellbeing, but new patchy hair loss should be evaluated by a dermatologist rather than treated as a cortisol problem.